Tianjin Chase Sun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 18.9% in First Half of 2022

Tianjin Chase Sun Pharmaceutical Co.,Ltd. (天津红日药业股份有限公司) (300026.SZ) reported a net profit of 348.8 million yuan in the first half of 2022, down 18.9% year-on-year.

Meanwhile, the company posted 3.3 billion yuan in revenue, down 5% year-on-year.

At the end of the reporting period, it had 11.8 billion yuan in total assets and 3.6 billion yuan in total liabilities, with a liability-to-asset ratio of 30.6%.